MyriadPro is Myriad’s digital provider portal where you can submit electronic test orders for Myriad myrisk, see any ordered test status, and receive all test results. Ready to sign up for MyriadPro? Talk to your local Myriad Account Executive or click below to see registration instructions.
Because patients and their families use test results to make life saving medical decisions, Myriad promises to provide affordable access to testing, a lifetime commitment to accurate results and comprehensive support for ALL appropriate patients and their families.
Blending both genetic test status and personal cancer family history, Myriad MyRisk hereditary cancer panel represents the next generation of hereditary cancer risk testing. Why Hereditary Cancer Testing with Myriad?
Patients with questions regarding their Myriad bill or insurance Explanation of Benefits should contact Myriad rather than their healthcare provider. To learn more about The Myriad Promise visit www.MyriadPromise.com
Patient results are sent instantly and securely to your linked MyriadPro account for fast online ordering. mySupport360 is an educational website to help guide your patients through their cancer journey every step of the way.
Test results will be available in about two to three weeks. Talk to your doctor about any questions, or learn more at one of our patient resource centers.
Through excellent insurance and financial assistance, 75% of patients who undergo myRisk testing pay $0 and 90% of patients pay $100 or less. It's Myriad's promise and commitment to provide patients with access to accurate and affordable genetic results.
One of the most compelling arguments in the gene patenting debate with the public has been the cost of the Myriad BRCA gene test: $3,000 per test, a price that many without insurance coverage cannot afford.
Results are available in 7-10 days.
Option 1 – Insurance Billing If the Insurance Billing option is selected on the Test Request Form, Myriad will verify coverage and determine the patient's financial responsibility. Myriad offers financial assistance to reduce out-of-pocket costs for qualified underinsured patients in the U.S. to no more than $295.
November 12, 2019 -- Myriad Genetics' Prequel Prenatal Screen cell-free DNA (cfDNA) test achieved high accuracy with no fetal fraction threshold, while maintaining a low test-failure rate of 1 in 1,000, in a study published in Ultrasound in Obstetrics & Gynecology.
Myriad's hereditary cancer testing products have been used to help millions of people make more informed healthcare choices. We offer testing for several inherited cancers including breast, ovarian, colon, skin (melanoma), uterine (endometrial), pancreatic, gastric and prostate cancer.
Ordering providers may, at time of ordering, elect to receive your results directly prior to the results releasing to your online account. You may ask your provider to release your results to your online account or call us at 888-268-6795 for more information.
Medicare typically covers genetic tests only when a beneficiary has signs or symptoms that can be further clarified by diagnostic testing. Medicare also covers some genetic tests that assess an individual's ability to metabolize certain drugs.
In order to ensure that a medical professional is available to review your results with you and answer any questions that you may have, we will not automatically release results to your online account over the weekend.
A positive result means that testing has identified a gene change or genetic mutation in one or more of the genes analyzed. This type of result may be called a pathogenic or disease-causing variant. A positive result typically means that you're at higher risk of developing a hereditary condition.
Find out if you are eligible for the Myriad Genetics MyRisk ™ Hereditary Cancer Test.
It is important that we better understand your family’s cancer history. Click Get started to answer two short questions that will help determine if MyRisk is right for you.